tradingkey.logo

HHS Winds Down mRNA Vaccine Development Under Barda

ReutersAug 5, 2025 9:55 PM

-

  • HHS: WINDS DOWN MRNA VACCINE DEVELOPMENT UNDER BARDA

  • HHS: WHILE SOME FINAL-STAGE CONTRACTS TO BE ALLOWED TO RUN THEIR COURSE, NO NEW MRNA-BASED PROJECTS WILL BE INITIATED

  • HHS: IN TOTAL, WIND DOWN AFFECTS 22 PROJECTS WORTH NEARLY $500 MILLION

Source text: [ID:]

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI